Overall and disease-free survival in patients treated with CRS + HIPEC with cisplatin and paclitaxel for gastric cancer with peritoneal carcinomatosis

BACKGROUND: Our experience regarding cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) was reviewed in terms of overall survival (OS) and disease-free survival (DFS) in patients with synchronous peritoneal carcinomatosis (SPC) and metachronous peritoneal carcinomatosi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Gastrointest Oncol
Asıl Yazarlar: Fugazzola, Paola, Coccolini, Federico, Montori, Giulia, Ceresoli, Marco, Baggi, Paolo, Costanzo, Antonio, Tomasoni, Matteo, Gregis, Francesco, Nozza, Silvia, Ansaloni, Luca
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AME Publishing Company 2017
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5506286/
https://ncbi.nlm.nih.gov/pubmed/28736644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2017.03.11
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller